aTyr Pharma | LIFE - Current Liabilities

Stock Price
0.85
Daily Change
-0.02 -2.02%
Monthly
-13.53%
Yearly
-78.59%
Q1 Forecast
0.82

aTyr Pharma reported $15.68M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Ardelyx USD 83.39M 1.67M Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
CSL USD 4.61B 207M Dec/2025
Curis USD 19.37M 745K Jun/2025
Galapagos EUR 152.86M 213.7M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Grifols EUR 2.53B 182.67M Sep/2025
Novartis USD 32B 286M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
United Therapeutics USD 560.6M 14.3M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025